Clinical trial
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and…
NCT00256269 · University of California, Irvine, Other · Terminated
Key facts
| NCT number | NCT00256269 |
|---|---|
| Title | Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma |
| Official title | A Phase II Study of Weekly Oxaliplatin and Irinotecan in the Treatment of Recurrent or Metastatic Esophageal Carcinoma and Carcinoma of the Gastroesophageal (GE) Junction |
| Lead sponsor | University of California, Irvine, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastroesophageal Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Irinotecan |
| Enrollment | 4 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 7, 2007 |
| Completion | Feb 7, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Jan 26, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: